Expression of a dominant negative IFN-γreceptor on mouse oligodendrocytes

GLIA

Volumn 51, Issue 1, 2005, Pages 22-34

  González, John M ^a   Bergmann, Cornelia C ^a   Fuss, Babette ^b   Hinton, David R ^a   Kangas, Cindy ^c   Macklin, Wendy B ^c   Stohlman, Stephen A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cytokine receptor; Oligodendrocytes; Transgenic mice

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; MESSENGER RNA; PROTEOLIPID PROTEIN; STAT1 PROTEIN; DNA BINDING PROTEIN; INTERFERON RECEPTOR; STAT1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENCEPHALITIS; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; IMMUNE RESPONSE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNITY; IMMUNOHISTOCHEMISTRY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPINAL CORD; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM; DNA-BINDING PROTEINS; FLOW CYTOMETRY; IMMUNITY; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; MICE; MYELIN PROTEOLIPID PROTEIN; OLIGODENDROGLIA; PHOSPHORYLATION; PLASMIDS; RECEPTORS, INTERFERON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPINAL CORD; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSGENES;

EID: 22444437948     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20182     Document Type: Article

References (83)

1. Anderson TJ, Montague P, Nadon N, Nave KA, Griffiths IR. 1997. Modification of Schwann cell phenotype with Plp transgenes: evidence that the PLP and DM20 isoproteins are targeted to different cellular domains. J Neurosci Res 50:13-22.
2. Andrews T, Zhang P, Bhat NR. 1998. TNFalpha potentiates IFN-gamma-induced cell death in oligodendrocyte progenitors. J Neurosci Res 54:574-583.
3. Bach EA, Aguet M, Schreiber RD. 1997. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 15: 563-591.
4. Baerwald KD, Popko B. 1998. Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J Neurosci Res 52:230-239.
5. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458-468.
6. Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J. 1988. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 78:318-323.
7. Bergmann CC, Yao Q, Stohlman SA. 1999. Microglia exhibit clonal variability in eliciting cytotoxic T lymphocyte responses independent of class I expression. Cell Immunol 198:44-53.
8. Bergmann CC, Parra B, Hinton DR, Chandran R, Morrison M, Stohlman SA. 2003. Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation. J Immunol 170:3204-3213.
9. Bergmann CC, Parra B, Hinton DR, Ramakrishna C, Dowdell KC, Stohlman SA. 2004. Perform and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J Virol 78:1739-17350.
10. Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, Meulepas E, Carton H. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 140:1506-1510.
11. Calabresi PA, Tranquill LR, McFarland HF, Cowan EP. 1998. Cytokine gene expression in cells derived from CSF of multiple sclerosis patients. J Neuroimmunol 89:198-205.
12. Cannella B, Raine CS. 2004. Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol 55: 46-57.
13. Chesler DA, Reiss CS. 2002. The role of IFN-gamma in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev 13:441-454.
14. Chu CQ, Wittmer S, Dalton DK. 2000. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med 192:123-128.
15. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B. 1996. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7:354-370.
16. Darnell JE Jr, Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
17. Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95:15623-15628.
18. Dettke M, Scheidt P, Prange H, Kirchner H. 1997. Correlation between interferon production and clinical disease activity in patients with multiple sclerosis. J Clin Immunol 17:293-300.
19. Dighe AS, Campbell D, Hsieh CS, Clarke S, Greaves DR, Gordon S, Murphy KM, Schreiber RD. 1995. Tissue-specific targeting of cytokine unresponsiveness in transgenic mice. Immunity 3:657-866.
20. Dighe AS, Farrar MA, Schreiber RD. 1993. Inhibition of cellular responsiveness to interferon-gamma (IFN gamma) induced by overexpression of inactive forms of the IFN gamma receptor. J Biol Chem 268:10645-10653.
21. Duong TT, St Louis J, Gilbert JJ, Finkelman FD, Strejan GH. 1992. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol 36:105-115.
22. Espejo C, Penkowa M, Saez-Torres I, Xaus J, Celada A, Montalban X, Martinez-Caceres EM. 2001. Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice. Exp Neurol 172:460-468.
23. Farrar MA, Fernandez-Luna J, Schreiber RD. 1991. Identification of two regions within the cytoplasmic domain of the human interferon-gamma receptor required for function. J Biol Chem 266:19626-19635.
24. Farrar MA, Campbell JD, Schreiber RD. 1992. Identification of a functionally important sequence in the C terminus of the interferon-gamma receptor. Proc Natl Acad Sci USA 89:11706-11710.
25. Fazakerley JK, Walker R. 2003. Virus demyelination. J Neurovirol 9:148-164.
26. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156:5-7.
27. Fleming JO, Trousdale MD, el-Zaatari FA, Stohlman SA, Weiner LP. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 58:869-875.
28. Fleming JO, Wang FI, Trousdale MD, Hinton DR, Stohlman SA. 1990. Immunopathogenesis of demyelination induced by MHV-4. Adv Exp Med Biol 276:565-572.
29. Frucht DM, Fukao T, Bogdan C, Schindler H, O'Shea JJ, Koyasu S. 2001. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol 22:556-560.
30. Furlan R, Brambilla E, Ruffini F, Poliani PL, Bergami A, Marconi PC, Franciotta DM, Penna G, Comi G, Adorini L, Martino G. 2001. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol 167:1821-1829.
31. Fuss B, Mallon B, Phan T, Ohlemeyer C, Kirchhoff F, Nishiyama A, Macklin WB. 2000. Purification and analysis of in vivo-differentiated oligodendrocytes expressing the green fluorescent protein. Dev Biol 218:259-274.
32. Fuss B, Afshari FS, Colello RJ, Macklin WB. 2001. Normal CNS myelination in transgenic mice overexpressing MHC class I H-2L(d) in oligodendrocytes. Mol Cell Neurosci 18:221-234.
33. Greenlund AC, Morales MO, Viviano BL, Yan H, Krolewski J, Schreiber RD. 1995. Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity 2:677-687.
34. Hart MN, Fabry Z. 1995. CNS antigen presentation. Trends Neurosci 18:475-481.
35. Hisahara S, Yuan J, Momoi T, Okano H, Miura M. 2001. Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination. J Exp Med 193:111-122.
36. Horwitz MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MB. 1997. Primary demyelination in transgenic mice expressing interferon-gamma. Nat Med 3:1037-1041.
37. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259:1742-1745.
38. Jensen NA, Pedersen KM, Celis JE, West MJ. 1998. Failure of central nervous system myelination in MBP/c-myc transgenic mice: evidence for c-myc cytotoxicity. Oncogene 16:2123-2129.
39. Kotenko SV, Izotova LS, Pollack BP, Mariano TM, Donnelly RJ, Muthukumaran G, Cook JR, Garotta G, Silvennoinen O, Ihle JN, Pestka S. 1995. Interaction between the components of the interferon gamma receptor complex. J Biol Chem 270:20915-20921.
40. Krakowski M, Owens T. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 26:1641-1646.
41. Krause CD, Lunn CA, Izotova LS, Mirochnitchenko O, Kotenko SV, Lundell DJ, Narula SK, Pestka S. 2000. Signaling by covalent heterodimers of interferon-gamma. Evidence for one-sided signaling in the active tetrameric receptor complex. J Biol Chem 275:22995-23004.
42. Leone DP, Genoud S, Atanasoski S, Grausenburger R, Berger P, Metzger D, Macklin WB, Chambon P, Suter U. 2003. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol Cell Neurosci 22:430-440.
43. Lin MT, Hinton DR, Stohlman SA. 1998. Mechanisms of viral clearance in perforin-deficient mice. Adv Exp Med Biol 440:431-436.
44. Lublin FD, Knobler RL, Kalman B, Goldhaber M, Marini J, Perrault M, D'Imperio C, Joseph J, Alkan SS, Korngold R. 1993. Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 16:267-274.
45. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-717.
46. Mallon BS, Shick HE, Kidd GJ, Macklin WB. 2002. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 22:876-885.
47. + T cells with highly focused specificity during viral persistence in the central nervous system. J Immunol 162:3905-3914.
48. Martin R, McFarland HF, McFarlin DE. 1992. Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153-187.
49. Molina-Holgado E, Vela JM, Arevalo-Martin A, Guaza C. 2001. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci 13:493-502.
50. Monteyne P, Van Laere V, Marichal R, Sindic CJ. 1997. Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis: detection by RT-PCR without in vitro stimulation. J Neuroimmunol 80:137-142.
51. Panitch HS, Hirsch RL, Haley AS, Johnson KP. 1987. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1:893-895.
52. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA. 1999. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 162:1641-1647.
53. Pearce BD, Hobbs MV, McGraw TS, Buchmeier MJ. 1994. Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J Virol 68:5483-5495.
54. Power C, Kong PA, Trapp BD. 1996. Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice. J Neurosci Res 44:165-173.
55. Pribyl TM, Campagnoni C, Kampf K, Handley VW, Campagnoni AT. 1996. The major myelin protein genes are expressed in the human thymus. J Neurosci Res 45:812-819.
56. Radja F, Kay DG, Albrecht S, Jolicoeur P. 2003. Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro. J Virol 77:11745-11753.
57. Rodriguez M, Lucchinetti CF. 1999. Is apoptotic death of the oligodendrocyte a critical event in the pathogenesis of multiple sclerosis? Neurology 53:1615-1616.
58. Rodriguez M, Leibowitz JL, Lampert PW. 1983. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol 13:426-433.
59. Rodriguez M, Zoecklein LJ, Howe CL, Pavelko KD, Gamez JD, Nakane S, Papke LM. 2003. Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection. J Virol 77:12252-12265.
60. Sakatsume M, Igarashi K, Winestock KD, Garotta G, Lamer AC, Finbloom DS. 1995. The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. J Biol Chem 270:17528-17534.
61. Satoh J, Kim SU, Kastrukoff LF, Takei F. 1991. Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes. J Neurosci Res 29:1-12.
62. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189.
63. Sethna MP, Lampson LA. 1991. Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J Neuroimmunol 34:121-132.
64. Shinar Y, McMorris FA. 1995. Developing oligodendroglia express mRNA for insulin-like growth factor-I, a regulator of oligodendrocyte development. J Neurosci Res 42:516-527.
65. Simmons RD, Willenborg DO. 1990. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J Neurol Sci 100:37-42.
66. Stohlman SA, Bergmann C, Cua D, Wege H, van der Veen R. 1994. Location of antibody epitopes within the mouse hepatitis virus nucleocapsid protein. Virology 202:146-153.
67. Suzumura A, Silberberg DH. 1988. MHC antigen expression on glial cells. Ann NY Acad Sci 540:495-497.
68. Suzumura A, Silberberg DH, Lisak RP. 1986. The expression of MHC antigens on oligodendrocytes: induction of polymorphic H-2 expression by lymphokines. J Neuroimmunol 11:179-190.
69. Torres C, Aranguez I, Rubio N. 1995. Expression of interferon-gamma receptors on murine oligodendrocytes and its regulation by cytokines and mitogens. Immunology 86:250-255.
70. Tran EH, Prince EN, Owens T. 2000. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J Immunol 164:2759-2768.
71. Tschen SI, Bergmann CC, Ramakrishna C, Morales S, Atkinson R, Stohlman SA. 2002. Recruitment kinetics and composition of anti-body-secreting cells within the central nervous system following viral encephalomyelitis. J Immunol 168:2922-2929.
72. Turnley AM, Miller JF, Bartlett PF. 1991a. Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-gamma and TNF-alpha. Neurosci Lett 123:45-48.
73. Turnley AM, Morahan G, Okano H, Bernard O, Mikoshiba K, Allison J, Bartlett PF, Miller JF. 1991b. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature 353:566-569.
74. Vartanian T, Li Y, Zhao M, Stefansson K. 1995. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1:732-743.
75. Vass K, Lassmann H. 1990. Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am J Pathol 137:789-800.
76. Voorthuis JA, Uitdehaag BM, De Groot CJ, Goede PH, van der Meide PH, Dijkstra CD. 1990. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin Exp Immunol 81:183-188.
77. Wight PA, Duchala CS, Readhead C, Macklin WB. 1993. A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice. J Cell Biol 123:443-454.
78. Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA. 1996. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 157:3223-3227.
79. Wong GH, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW. 1984. Inducible expression of H-2 and Ia antigens on brain cells. Nature 310:688-691.
80. Wong GH, Bartlett PF, Clark-Lewis I, McKimm-Breschkin JL, Schrader JW. 1985. Interferon-gamma induces the expression of H-2 and Ia antigens on brain cells. J Neuroimmunol 7:255-278.
81. Woodroofe MN, Cuzner ML. 1993. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 5:583-558.
82. + T cell epitope within the M protein of a neurotropic coronavirus. Virology 208:173-179.
83. Yoshioka T, Feigenbaum L, Jay G. 1991. Transgenic mouse model for central nervous system demyelination. Mol Cell Biol 11:5479-5486.